How An HIV Drug Is Now Helping People With Genetic Diseases

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
Commercial Appeal

Forty years ago, AIDS was a death sentence. Not today, but HIV is still a health threat

Lynn Norment, a columnist for The Commercial Appeal, is a former editor for Ebony Magazine. It’s not shocking or even surprising that HIV and AIDS are on the rise in today’s world. The dreaded disease ...
Rolling Out

How HIV drugs have advanced to improve health

The 1980s painted a bleak picture for those diagnosed with HIV/AIDS. It was a death sentence shrouded in fear and uncertainty. Yet, during that bleak era, a beacon of hope ignited: antiretroviral ...

HIV funding still falls short of targets after pledges: What's at stake

The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving ...
FiercePharma

Potential federal budget cuts won't rock Gilead's HIV boat too much: analysts

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top HIV drug maker Gilead Sciences last week. But, according to analysts at ...
STAT

HIV self-testing is easy, effective — and underutilized

Assoumou is an infectious diseases physician-scientist at Boston Medical Center. Miller is a research data associate within Dr. Assoumou’s I-CARE (Infectious Complications Assessment and Research) lab ...
Nasdaq

Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment

ORLANDO, Fla., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today announced a milestone in its transformative ...